<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799981</url>
  </required_header>
  <id_info>
    <org_study_id>YA-LOF-0015</org_study_id>
    <nct_id>NCT00799981</nct_id>
  </id_info>
  <brief_title>A Comparison of Two Urinary Catheters of Different Lengths for Female Use, in Intermittent Catheterization</brief_title>
  <official_title>A Multi Centre, Single-blind, Randomized, Cross-over Study Comparing Two Female Catheters With Different Length in Terms of Residual Urine After Intermittent Catheterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wellspect HealthCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wellspect HealthCare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study comparing a 10 cm catheter with a 7 cm catheter in a group of female patients who, on&#xD;
      a routine bases, empty their bladder using urinary catheters, by measuring residual urine&#xD;
      after intermittent catheterization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study personnel will conduct three bladder scans after each catheterization in order to&#xD;
      obtain the mean residual urine volume. Each patient will catheterize herself two times with&#xD;
      each product, i.e. a total of four catheterizations.&#xD;
&#xD;
      Diagnosis and BMI will be collected at visit 1 to assess whether the residual urine volume&#xD;
      differs between these subgroups.&#xD;
&#xD;
      The hypothesis that the mean residual volumes were equal when using the 7 and the 10&#xD;
      centimeter catheters was tested by means of the Wilcoxon signed rank test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study was designed as a randomised, single blind, cross-over study to eliminate bias.&#xD;
Every subject was catheterisized with both 7 cm and 10 cm long catheters.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>The subjects were handed out numbered boxes with the catheter randomised to be used and then cathererisized by herself.&#xD;
The investigator was blinded to which catheter was used.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Bladder Scan Measurements of Residual Urine Volume</measure>
    <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
    <description>Measurements were performed with the bladder scan BVI 3000. The primary outcome variable was average residual urine volume (mL) calculated from repetitive bladder scans performed after each catheterization.&#xD;
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With a Residual Volume &gt;5mL or ≤5mL</measure>
    <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. At least 2 hours had to pass between 2 catheterizations.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With a Residual Volume &gt;10mL or ≤10mL</measure>
    <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With a Residual Volume &gt;30mL or ≤30mL</measure>
    <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Subjects With a Residual Volume &gt;50mL or ≤50mL</measure>
    <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Does the Subject's Bladder Feel Completely Empty After Catheterisation (All Subjects)</measure>
    <time_frame>Question asked minutes after catheterization.</time_frame>
    <description>After each catheterization the study nurse will ask the subject whether it feels as if the bladder is completely emptied or not.&#xD;
0=No and 1=Yes.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Catheterization</condition>
  <arm_group>
    <arm_group_label>AABB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 7 cm then 7 cm then 10 cm then 10 cm&#xD;
Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABAB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 7 cm then 10 cm then 7 cm then 10 cm&#xD;
Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABBA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 7 cm then 10 cm then 10 cm then 7 cm&#xD;
Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BAAB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 10 cm then 7 cm then 7 cm then 10 cm&#xD;
Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BABA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 10 cm then then 7 cm then 10 cm then 7 cm&#xD;
Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BBAA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 10 cm then 10 cm then 7 cm then 7 cm&#xD;
Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>A=SpeediCath Compact 7 cm and B=POBE 10 cm</intervention_name>
    <description>Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.</description>
    <arm_group_label>AABB</arm_group_label>
    <arm_group_label>ABAB</arm_group_label>
    <arm_group_label>ABBA</arm_group_label>
    <arm_group_label>BAAB</arm_group_label>
    <arm_group_label>BABA</arm_group_label>
    <arm_group_label>BBAA</arm_group_label>
    <other_name>Coloplast SpeediCath Compact 7 cm</other_name>
    <other_name>Astra Tech POBE 10 cm</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of signed informed consent&#xD;
&#xD;
          -  Female subjects aged 18 years and over&#xD;
&#xD;
          -  Experienced users of CIC with a minimum of one month of use&#xD;
&#xD;
          -  Practice CIC a minimum of 1 time per day&#xD;
&#xD;
          -  Practice CIC with female catheters with a maximum length of 20 cm&#xD;
&#xD;
          -  Perform self-catheterization&#xD;
&#xD;
          -  Sufficient hand function to be able to open and handle catheter packages&#xD;
&#xD;
          -  Use catheters with Ch 10, 12 or 14&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Ongoing symptomatic UTI&#xD;
&#xD;
          -  Involvement in the planning and conduct of the study (applies to both Astra Tech staff&#xD;
             or staff at the study site)&#xD;
&#xD;
          -  Previous enrolment or randomisation of treatment in the present study&#xD;
&#xD;
          -  Participation in another clinical study during the study period&#xD;
&#xD;
          -  Severe non-compliance to protocol as judged by the investigator and/or Astra Tech&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf Malmqvist, MD, PhD, Assoc.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research and Trial Centre, Lund University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rehabiliteringskliniken, Södra Älvsborgs Sjukhus</name>
      <address>
        <city>Borås</city>
        <zip>SE-501 82</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Verksamhet Urologi, Sahlgrenska Universitetssjukhuset</name>
      <address>
        <city>Gothenburg</city>
        <zip>SE-413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research and Trial Centre, Lund University Hospital</name>
      <address>
        <city>Lund</city>
        <zip>SE-221 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 28, 2008</study_first_submitted>
  <study_first_submitted_qc>November 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>April 26, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 18, 2021</results_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Each subject eligible for entry into the study was a female using catheters for intermittent self catheterization at least once a day and had done so for the last month.&#xD;
Three centers in Sweden were involved. Four catheterizations, two with each product in a randomized order, were performed at the study centre.&#xD;
Catheterization should resemble the daily use as far as possible.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>AABB</title>
          <description>7 cm then 7 cm then 10 cm then 10 cm&#xD;
B=Astra Tech POBE catheter, 10 cm A=Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
        </group>
        <group group_id="P2">
          <title>ABAB</title>
          <description>7 cm then 10 cm then 7 cm then 10 cm&#xD;
B=Astra Tech POBE catheter, 10 cm A=Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
        </group>
        <group group_id="P3">
          <title>ABBA</title>
          <description>7 cm then 10 cm then 10 cm then 7 cm&#xD;
B=Astra Tech POBE catheter, 10 cm A=Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
        </group>
        <group group_id="P4">
          <title>BAAB</title>
          <description>10 cm then 7 cm then 7 cm then 10 cm&#xD;
B=Astra Tech POBE catheter, 10 cm A=Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
        </group>
        <group group_id="P5">
          <title>BABA</title>
          <description>10 cm then 7 cm then 10 cm then 7 cm&#xD;
B=Astra Tech POBE catheter, 10 cm A=Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
        </group>
        <group group_id="P6">
          <title>BBAA</title>
          <description>10 cm then 10 cm then 7 cm then 7 cm&#xD;
B=Astra Tech POBE catheter, 10 cm A=Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="11"/>
                <participants group_id="P6" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="10"/>
                <participants group_id="P4" count="10"/>
                <participants group_id="P5" count="11"/>
                <participants group_id="P6" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Four Catheterizations, Each Subject Was Catheterisized Twice With Each Product in a Randomized Order</title>
          <description>A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 6 arms with the following order of catheters used: AABB ABAB ABBA BAAB BABA BBAA BBAA</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.20" spread="15.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Kilogramme</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.53" spread="13.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>Cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="163.62" spread="7.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.78" spread="4.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Bladder Scan Measurements of Residual Urine Volume</title>
        <description>Measurements were performed with the bladder scan BVI 3000. The primary outcome variable was average residual urine volume (mL) calculated from repetitive bladder scans performed after each catheterization.&#xD;
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated.</description>
        <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
        <population>All subjects in the investigation</population>
        <group_list>
          <group group_id="O1">
            <title>7 cm</title>
            <description>All study participants were catheterizised with both catheters twice in a randomized order.&#xD;
Every subject is its' own control.</description>
          </group>
          <group group_id="O2">
            <title>10 cm</title>
            <description>All study participants were catheterizised with both catheters twice in a randomized order.&#xD;
Every subject is its' own control.</description>
          </group>
        </group_list>
        <measure>
          <title>Bladder Scan Measurements of Residual Urine Volume</title>
          <description>Measurements were performed with the bladder scan BVI 3000. The primary outcome variable was average residual urine volume (mL) calculated from repetitive bladder scans performed after each catheterization.&#xD;
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated.</description>
          <population>All subjects in the investigation</population>
          <units>Residual volume in mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.74" spread="41.48"/>
                    <measurement group_id="O2" value="34.78" spread="38.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The hypothesis that a 10 cm catheter provides equal emptying of the bladder as a 7 cm catheter was tested.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.8762</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With a Residual Volume &gt;5mL or ≤5mL</title>
        <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. At least 2 hours had to pass between 2 catheterizations.</time_frame>
        <population>All subjects participating in the investigation.</population>
        <group_list>
          <group group_id="O1">
            <title>7 cm</title>
            <description>Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
          <group group_id="O2">
            <title>10 cm</title>
            <description>Astra Tech POBE catheter, 10 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With a Residual Volume &gt;5mL or ≤5mL</title>
          <population>All subjects participating in the investigation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&gt; 5 mL</title>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>≤ 5 mL</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.7905</p_value>
            <method>McNemar</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With a Residual Volume &gt;10mL or ≤10mL</title>
        <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
        <population>All subjecs participating in the investigation.</population>
        <group_list>
          <group group_id="O1">
            <title>7 cm</title>
            <description>Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
          <group group_id="O2">
            <title>10 cm</title>
            <description>Astra Tech POBE catheter, 10 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With a Residual Volume &gt;10mL or ≤10mL</title>
          <population>All subjecs participating in the investigation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&gt;10mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≤10mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>1.00</p_value>
            <method>McNemar</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With a Residual Volume &gt;30mL or ≤30mL</title>
        <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
        <population>All subjects in the investigation.</population>
        <group_list>
          <group group_id="O1">
            <title>7 cm</title>
            <description>Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
          <group group_id="O2">
            <title>10 cm</title>
            <description>Astra Tech POBE catheter, 10 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With a Residual Volume &gt;30mL or ≤30mL</title>
          <population>All subjects in the investigation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&gt;30mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≤30mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Subjects With a Residual Volume &gt;50mL or ≤50mL</title>
        <time_frame>Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.</time_frame>
        <population>All subjects participating in the investigation.</population>
        <group_list>
          <group group_id="O1">
            <title>7 cm</title>
            <description>Coloplast SpeediCath Compact catheter, 7 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
          <group group_id="O2">
            <title>10 cm</title>
            <description>Astra Tech POBE catheter, 10 cm&#xD;
Four catheterizations, two with each product in a randomized order.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Subjects With a Residual Volume &gt;50mL or ≤50mL</title>
          <population>All subjects participating in the investigation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&gt;50mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≤50mL</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Does the Subject's Bladder Feel Completely Empty After Catheterisation (All Subjects)</title>
        <description>After each catheterization the study nurse will ask the subject whether it feels as if the bladder is completely emptied or not.&#xD;
0=No and 1=Yes.</description>
        <time_frame>Question asked minutes after catheterization.</time_frame>
        <population>All subjects participating in the investigation.</population>
        <group_list>
          <group group_id="O1">
            <title>All Subjects</title>
            <description>All study participants were catheterizised with both catheters twice in a randomized order.&#xD;
Every subject is its' own control. The results of the bladder scan for cathetersization with the 7 cm long catheter minus the 10 cm long catheter shows the difference in residual volume..</description>
          </group>
        </group_list>
        <measure>
          <title>Does the Subject's Bladder Feel Completely Empty After Catheterisation (All Subjects)</title>
          <description>After each catheterization the study nurse will ask the subject whether it feels as if the bladder is completely emptied or not.&#xD;
0=No and 1=Yes.</description>
          <population>All subjects participating in the investigation.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>7 cm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.75" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 cm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 cm - 10 cm</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>In the table 0=No and 1=Yes.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.0273</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The investigation lasted for 3 months and the adverse events/adverese device effects were collected during this time.</time_frame>
      <desc>The term adverse events will be used together with the term adverse device effects in this system due to limitations in choise in reporting.</desc>
      <group_list>
        <group group_id="E1">
          <title>7 cm</title>
          <description>Coloplast SpeediCath Compact catheter, 7 cm Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
        </group>
        <group group_id="E2">
          <title>10 cm</title>
          <description>Astra Tech POBE catheter, 10 cm Four catheterizations in total, two catheterizations with each study product in a randomized order.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Burning sensation in urethra one hour after catheterization</sub_title>
                <description>One subject in the investigational group (10 cm catheter) reported burning sensation in urethra one hour after catheterization possibly due to the catheter. The burning sensation disappeared without any action taken.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Menstrual bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head of Medical Affairs</name_or_title>
      <organization>Wellspect Health Care</organization>
      <phone>+46313763000</phone>
      <email>mace@wellspect.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

